Yahoo
Generation Bio (GBIO) delivered earnings and revenue surprises of 12% and 464.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid-2025 - Cash balance of $157.6 million expected to fund operations into 2H 2027 CAMBRIDGE, MASS., May 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with
Yahoo
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th at 12:45 p.m. ET. A live webcast of the presentation will be available on the investor section of the c
Yahoo
Generation Bio (GBIO) delivered earnings and revenue surprises of -14.29% and 6.95%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
- Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 - Cash balance of $185.2 million expected to fund operations into 2H 2027 CAMBRIDGE, MASS., March 13, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, reported business highlights and fourth
Yahoo
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. ET in Boston. A live webcast of the presentation will be available on the investor section of the company’s website at
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTC | 57.99% | $4.48B | 0.15% |
IWC | 56.49% | $766.88M | 0.6% |
XBI | 54.39% | $4.85B | 0.35% |
KJUL | 53.93% | $113.35M | 0.79% |
GNOM | 53.54% | $40.65M | 0.5% |
IWM | 53.18% | $63.95B | 0.19% |
VTWO | 52.98% | $12.07B | 0.07% |
ARKG | 52.95% | $944.78M | 0.75% |
IWO | 52.50% | $11.36B | 0.24% |
GSSC | 51.87% | $538.65M | 0.2% |
IWN | 51.63% | $11.10B | 0.24% |
KJAN | 51.15% | $305.13M | 0.79% |
PBE | 51.04% | $214.12M | 0.58% |
PRFZ | 50.91% | $2.33B | 0.34% |
IBB | 50.90% | $5.22B | 0.45% |
SCHA | 50.05% | $16.91B | 0.04% |
IJT | 49.80% | $6.01B | 0.18% |
IJR | 49.58% | $79.01B | 0.06% |
PSC | 49.42% | $811.78M | 0.38% |
SPSM | 49.27% | $11.14B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -39.41% | $109.64M | 0.85% |
BTAL | -32.30% | $361.41M | 1.43% |
TAIL | -30.82% | $140.49M | 0.59% |
SHYM | -14.91% | $322.93M | 0.35% |
ULST | -14.18% | $637.77M | 0.2% |
IBMN | -13.99% | $446.12M | 0.18% |
IVOL | -13.76% | $353.94M | 1.02% |
FTSD | -13.69% | $212.46M | 0.25% |
CLIP | -12.04% | $1.50B | 0.07% |
XONE | -11.91% | $603.24M | 0.03% |
GBIL | -10.04% | $6.17B | 0.12% |
FXY | -9.55% | $838.61M | 0.4% |
XHLF | -7.87% | $1.46B | 0.03% |
CGSM | -7.45% | $658.61M | 0.25% |
CTA | -7.40% | $1.05B | 0.76% |
TPMN | -7.31% | $31.54M | 0.65% |
BSMW | -6.97% | $102.62M | 0.18% |
LDUR | -6.65% | $849.09M | 0.5% |
BIL | -6.55% | $45.95B | 0.1356% |
AGZ | -6.51% | $607.46M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UGA | -0.07% | $73.47M | 0.97% |
BSSX | -0.09% | $75.11M | 0.18% |
TYA | 0.14% | $149.38M | 0.15% |
STXT | 0.17% | $134.15M | 0.49% |
IBTP | 0.17% | $129.44M | 0.07% |
BWX | 0.23% | $1.41B | 0.35% |
JMST | -0.29% | $3.65B | 0.18% |
SCHO | -0.36% | $10.87B | 0.03% |
IBTK | -0.44% | $431.59M | 0.07% |
IBTF | 0.46% | $2.12B | 0.07% |
SHM | -0.48% | $3.37B | 0.2% |
FMF | -0.50% | $153.73M | 0.95% |
CANE | -0.51% | $10.71M | 0.29% |
SPTI | 0.53% | $8.70B | 0.03% |
DBE | 0.56% | $48.48M | 0.77% |
UDN | 0.59% | $137.74M | 0.78% |
SHY | 0.59% | $24.03B | 0.15% |
TBLL | 0.61% | $2.46B | 0.08% |
CARY | -0.61% | $347.36M | 0.8% |
LGOV | 0.61% | $684.47M | 0.67% |
Current Value
$0.371 Year Return
Current Value
$0.371 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
K | -18.84% | $28.49B | +32.17% | 2.77% |
CBOE | -16.34% | $22.95B | +20.67% | 1.12% |
FMTO | -15.52% | $45.74M | -99.96% | 0.00% |
CCEC | -8.41% | $1.02B | +3.91% | 2.71% |
VSA | -5.58% | $7.04M | -49.24% | 0.00% |
CIG.C | -5.52% | $2.45B | +9.77% | 0.00% |
CME | -4.98% | $98.74B | +28.80% | 3.84% |
CHD | -4.94% | $23.29B | -11.36% | 1.23% |
BULL | -4.01% | $5.67B | +11.22% | 0.00% |
KMB | -3.96% | $45.57B | +1.99% | 3.58% |
EW | -2.73% | $45.10B | -14.68% | 0.00% |
LITB | -2.53% | $21.28M | -72.45% | 0.00% |
STG | -2.45% | $27.05M | -37.35% | 0.00% |
ED | -2.17% | $36.75B | +5.26% | 3.28% |
EDU | -2.00% | $7.99B | -41.11% | 0.00% |
SO | -1.73% | $96.04B | +10.08% | 3.29% |
FATBB | -1.58% | $50.77M | -11.65% | 9.83% |
HUSA | -1.46% | $9.73M | -55.71% | 0.00% |
BTCT | -1.20% | $25.35M | +93.08% | 0.00% |
AQB | -0.93% | $2.96M | -61.58% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CERS | 47.62% | $246.60M | -34.18% | 0.00% |
ENOV | 46.11% | $2.04B | -31.55% | 0.00% |
IDYA | 46.05% | $1.52B | -58.32% | 0.00% |
KN | 45.71% | $1.48B | -2.96% | 0.00% |
BEAM | 45.60% | $1.73B | -27.49% | 0.00% |
ATXS | 45.54% | $225.17M | -57.69% | 0.00% |
ATNM | 45.03% | $47.73M | -84.47% | 0.00% |
JOE | 44.54% | $2.70B | -20.53% | 0.91% |
KYMR | 44.46% | $1.95B | -15.67% | 0.00% |
EXP | 44.45% | $7.81B | -9.16% | 0.42% |
IMNM | 44.43% | $696.10M | -44.44% | 0.00% |
UFPI | 44.14% | $6.12B | -15.17% | 1.32% |
SITE | 43.23% | $5.50B | -19.85% | 0.00% |
PHR | 43.20% | $1.51B | +6.90% | 0.00% |
BANF | 43.02% | $4.26B | +40.48% | 1.42% |
CRBU | 42.95% | $78.11M | -76.60% | 0.00% |
BOC | 42.67% | $453.87M | +4.64% | 0.00% |
RLGT | 42.66% | $292.29M | +16.76% | 0.00% |
RCKT | 42.62% | $724.54M | -71.26% | 0.00% |
TMP | 42.55% | $937.81M | +34.37% | 3.81% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GFI | -0.01% | $18.61B | +31.67% | 2.75% |
CYD | -0.03% | $643.06M | +106.88% | 2.24% |
CYCN | -0.10% | $9.37M | +2.39% | 0.00% |
PG | 0.11% | $380.78B | -3.25% | 2.51% |
DG | -0.21% | $20.45B | -36.56% | 2.55% |
SRRK | 0.21% | $2.92B | +115.29% | 0.00% |
NEUE | 0.43% | $62.05M | +13.56% | 0.00% |
UNH | 0.43% | $248.87B | -47.37% | 3.06% |
UUU | 0.44% | $4.93M | +40.20% | 0.00% |
MO | 0.48% | $97.80B | +26.35% | 6.94% |
CL | 0.52% | $72.64B | -5.18% | 2.25% |
T | 0.76% | $196.66B | +57.98% | 4.07% |
MSIF | -0.77% | $715.25M | +28.42% | 7.05% |
PPC | -0.81% | $11.21B | +41.54% | 0.00% |
DUK | 0.87% | $90.12B | +12.74% | 3.61% |
PULM | -0.88% | $23.82M | +239.64% | 0.00% |
AQB | -0.93% | $2.96M | -61.58% | 0.00% |
BTCT | -1.20% | $25.35M | +93.08% | 0.00% |
KO | 1.43% | $308.23B | +13.09% | 2.75% |
HUSA | -1.46% | $9.73M | -55.71% | 0.00% |